Case Studies-5

Our API base meets the modern generic drug R&D and API production requirements of FDA and CGMP, and is an export-oriented high-end pharmaceutical raw material production base based on EHS requirements of ISO and OSHA and cGMP standards of FDA and EU, and will soon be inspected by FDA and EU cGMP. At present, we have successfully exported to many international markets such as USA, Europe, Russia, India, Bangladesh, Pakistan and Uzbekistan. The company has completed a number of API innovative technology research in several therapeutic areas such as cardiovascular, cerebrovascular, digestive, antifungal, antiviral, etc. We strive to achieve 20-24 new generic API projects in the next 3-5 years, in addition to meeting the raw material needs of Qirui Pharmaceuticals, a preparation plant under Qirui Group, all of which are declared according to international regulatory requirements FDADMF in the US, EDMF and COS in Europe, towards international market.

MORE CASE

Case Studies -1

Case Studies-2

Case Studies-3

Case Studies-4

Case Studies-5

Case Studies-6